tradingkey.logo

tradingkey.logo
怜玢


Aptevo Therapeutics Inc

APVO
りォッチリストに远加
0.594USD
-0.066-10.00%
終倀 11-13 16:00ET
1.08M時䟡総額
0.00盎近12ヶ月PER

Aptevo Therapeutics Incに぀いお 䌁業名

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for the treatment of cancer. The Company has two clinical candidates: Mipletamig and ALG.APV-527. Mipletamig is being evaluated in RAINIER, a two-part Phase 1b/2 trial for the treatment of frontline acute myeloid leukemia in combination with standard-of-care venetoclax + azacitidine. Mipletamig has received orphan drug designation for AML according to the Orphan Drug Act. ALG.APV-527, a bispecific conditional 4-1BB agonist, only active upon simultaneous binding to 4-1BB and 5T4, is being co-developed with Alligator Bioscience and is being evaluated in a Phase 1 clinical trial for the treatment of multiple solid tumor types likely to express 5T4. The Company has three pre-clinical candidates with different mechanisms of action designed to target a range of solid tumors. All pipeline candidates are created from two proprietary platforms, ADAPTIR and ADAPTIR-FLEX.

Aptevo Therapeutics Inc プロフィヌル


䌁業コヌドAPVO
䌚瀟名Aptevo Therapeutics Inc
䞊堎日Jul 20, 2016
最高経営責任者「CEO」White (Marvin L)
埓業員数37
蚌刞皮類Ordinary Share
決算期末Jul 20
本瀟所圚地2401 4th Ave Ste 1050
郜垂SEATTLE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号98121-3460
電話番号12068380500
りェブサむトhttps://aptevotherapeutics.com/
䌁業コヌドAPVO
䞊堎日Jul 20, 2016
最高経営責任者「CEO」White (Marvin L)

Aptevo Therapeutics Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Marvin L. White
Mr. Marvin L. White
Executive Chairman of the Board
Executive Chairman of the Board
1.26K
--
Mr. Jeffrey G. Lamothe
Mr. Jeffrey G. Lamothe
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
961.00
--
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Director
Independent Director
400.00
--
Ms. Barbara Lopez Kunz
Ms. Barbara Lopez Kunz
Independent Director
Independent Director
400.00
--
Dr. John E. Niederhuber, M.D.
Dr. John E. Niederhuber, M.D.
Lead Independent Director
Lead Independent Director
400.00
--
Mr. Daniel J. Abdun-Nabi, J.D.
Mr. Daniel J. Abdun-Nabi, J.D.
Independent Director
Independent Director
--
--
Mr. Grady Grant, III
Mr. Grady Grant, III
Independent Director
Independent Director
--
--
Ms. So Young Kwon
Ms. So Young Kwon
Senior Vice President, General Counsel, Business Development and Corporate Affairs
Senior Vice President, General Counsel, Business Development and Corporate Affairs
--
--
Ms. Daphne L. Taylor
Ms. Daphne L. Taylor
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Marvin L. White
Mr. Marvin L. White
Executive Chairman of the Board
Executive Chairman of the Board
1.26K
--
Mr. Jeffrey G. Lamothe
Mr. Jeffrey G. Lamothe
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
961.00
--
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Director
Independent Director
400.00
--
Ms. Barbara Lopez Kunz
Ms. Barbara Lopez Kunz
Independent Director
Independent Director
400.00
--
Dr. John E. Niederhuber, M.D.
Dr. John E. Niederhuber, M.D.
Lead Independent Director
Lead Independent Director
400.00
--
Mr. Daniel J. Abdun-Nabi, J.D.
Mr. Daniel J. Abdun-Nabi, J.D.
Independent Director
Independent Director
--
--

よくある質問

Aptevo Therapeutics Incの䞊䜍5名の株䞻は誰ですか


Aptevo Therapeutics Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Marvin L. White

Aptevo Therapeutics IncAPVOの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Aptevo Therapeutics Incの株匏を保有しおいる機関は38瀟あり、保有株匏の総垂堎䟡倀は玄55.65Kで、党䜓の4.71%を占めおいたす。2025Q4ず比范しお、機関の持ち株は16735.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。